Related Experiment Video
Updated: Aug 15, 2026
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
Synthesis and evaluation of the diarylthiourea analogs as novel anti-cancer agents
Shengquan Liu1, Maggie C Louie2, Vanishree Rajagopalan1
1College of Pharmacy, Touro University-California, Vallejo, CA 94592, USA.
Abstract:
Ten p-nitrodiarylthiourea analogs were designed, synthesized and evaluated in breast (MCF-7, T-47D, MDA-MB-453) and prostate (DU-145, PC-3, LNCaP) cancer cell lines for their anticancer activities. The majority of the compounds were able to inhibit the growth of these six cancer cell lines at low micromolar concentrations. Compound 7 was found to be the most potent anticancer agent in this series with GI50 values of 3.16μM for MCF-7, 2.53μM for T-47D, 4.77μM for MDA-MB-453 breast cancer lines and 3.54μM for LNCaP prostate cancer cell line. These GI50 values were comparable to the parent compound, SHetA2.
Insights
Ten novel p-nitrodiarylthiourea compounds were synthesized and tested against breast and prostate cancer cells. Compound 7 demonstrated significant anticancer activity, showing potency comparable to SHetA2.
Area of Science:
- Medicinal Chemistry
- Oncology
- Pharmacology
Background:
- Breast and prostate cancers represent significant global health challenges.
- Developing novel therapeutic agents is crucial for improving patient outcomes.
- Diarylthiourea derivatives have shown promise as anticancer agents.
Purpose of the Study:
- To design and synthesize novel p-nitrodiarylthiourea analogs.
- To evaluate the in vitro anticancer activities of these compounds against human breast and prostate cancer cell lines.
- To identify lead compounds with potent cytotoxic effects.
Main Methods:
- Synthesis of ten p-nitrodiarylthiourea analogs.
- In vitro evaluation of anticancer activity using breast cancer cell lines (MCF-7, T-47D, MDA-MB-453) and prostate cancer cell lines (DU-145, PC-3, LNCaP).
- Determination of GI50 values to quantify compound potency.
Main Results:
- The majority of synthesized compounds exhibited anticancer activity at low micromolar concentrations.
- Compound 7 emerged as the most potent analog in the series.
- Compound 7 displayed GI50 values of 3.16μM (MCF-7), 2.53μM (T-47D), 4.77μM (MDA-MB-453), and 3.54μM (LNCaP).
- The observed potency of Compound 7 was comparable to the parent compound, SHetA2.
Conclusions:
- The synthesized p-nitrodiarylthiourea analogs possess significant anticancer potential.
- Compound 7 is a promising candidate for further investigation as an anticancer therapeutic.
- This study contributes to the development of novel anticancer agents targeting breast and prostate cancers.
